| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/04/2001 | EP1112262A1 SUBSTITUTED $g(g)-PHENYL-$g(D)-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO |
| 07/04/2001 | EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 07/04/2001 | EP1112253A1 Branched alkyl pyrrolidine-3-carboxylic acids |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP1112082A2 Stable liquid formulations of botulinum toxin |
| 07/04/2001 | EP1112074A1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 07/04/2001 | EP1112073A1 Calcilytic compounds |
| 07/04/2001 | EP1112070A1 Novel substituted triazole compounds |
| 07/04/2001 | EP1112063A1 Lipstatin derivative-soluble fiber tablets |
| 07/04/2001 | EP1112003A2 Composition comprising a viscosity modulating polymer material and its use |
| 07/04/2001 | EP0850236B1 Piperazino derivatives as neurokinin antagonists |
| 07/04/2001 | CN1302330A Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 07/04/2001 | CN1302297A Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in control of helicobacter bacteria |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302204A Novel fatty analogues for treatment of diabetes |
| 07/04/2001 | CN1301571A Development method for pylorus helicobacterium adhesion agent HpaA gene engineering vaccine |
| 07/04/2001 | CN1301568A Chinese Angelica blood replonishing oral liquid and producing process |
| 07/04/2001 | CN1301560A Method for preparing medicine for curing gastropathy |
| 07/04/2001 | CN1301552A Method for producing medicine for curing vertigo |
| 07/04/2001 | CN1301541A Health care product containing lactein and its preparing method |
| 07/04/2001 | CN1301535A Use of curcumin to treat hepatitis B |
| 07/04/2001 | CN1067999C Anti-helicobacter heterocyclic derivatives of azolines |
| 07/04/2001 | CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors |
| 07/04/2001 | CN1067900C Medicine bolus for hepatitis B and its preparing method |
| 07/04/2001 | CN1067893C Cane sugar-free notoginseng flower essence and its preparation |
| 07/04/2001 | CN1067888C Liquid for curing hepatitis and its preparing method |
| 07/04/2001 | CN1067883C Traditional Chinese medicine for curing cirrhosis of lever and its preparing method |
| 07/04/2001 | CN1067882C Medicinal flavouring for curing hepatic disease |
| 07/03/2001 | US6255512 High energy oxidizing agents in explosive compositions, propellant formulations, gas-generating compositions, andpharmaceutical agents |
| 07/03/2001 | US6255351 Treatment of bone disorders |
| 07/03/2001 | US6255320 Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
| 07/03/2001 | US6255319 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as 5-ht4 receptor ligands |
| 07/03/2001 | US6255290 Reducing sensitivity to skin cancer; topical administering of nucleotide |
| 07/03/2001 | US6255281 Complexing uteroglobin to fibronectin |
| 07/03/2001 | US6254886 Multilayer tablet |
| 07/03/2001 | US6254863 Decreasing morbidity and mortality with infection by porphyromonas |
| 07/03/2001 | US6254853 Drugs with carriers |
| 07/03/2001 | US6254850 Polycarboxyalkylaminoalkanes for complexes |
| 07/03/2001 | CA2166891C Method for making freeze dried drug dosage forms |
| 07/03/2001 | CA2116348C Sirs vaccine and diagnosis method |
| 07/03/2001 | CA2012115C Iodinated somatostatins |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/29/2001 | CA2329576A1 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-ht1d receptor selective antagonists |
| 06/28/2001 | WO2001046475A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046263A1 Novel compounds |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046206A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046205A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046204A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 06/28/2001 | WO2001046203A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046196A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 06/28/2001 | WO2001046191A1 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives |
| 06/28/2001 | WO2001046189A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 06/28/2001 | WO2001046184A1 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046183A1 SUBSTITUTED 1,3,4-OXADIAZOLES AND A METHOD OF REDUCING TNF-α LEVELS |
| 06/28/2001 | WO2001046176A2 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | WO2001046174A1 Novel compounds |
| 06/28/2001 | WO2001046168A1 Tryptase inhibitors |
| 06/28/2001 | WO2001046151A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/28/2001 | WO2001046136A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046132A1 Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease |
| 06/28/2001 | WO2001046128A2 Tryptase inhibitors |
| 06/28/2001 | WO2001045749A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | WO2001045736A1 Procedure to use staphylococcal bacteria |
| 06/28/2001 | WO2001045735A2 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 06/28/2001 | WO2001045725A2 Treatment for inflammatory bowel disease (ibd) and related conditions |
| 06/28/2001 | WO2001045715A2 Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain |
| 06/28/2001 | WO2001045714A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045709A1 Substituted piperazine and piperidine calcium channel blockers |
| 06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | WO2001045702A1 SUBSTITUTED ACYLHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 06/28/2001 | WO2001045695A2 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 06/28/2001 | WO2001045694A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045691A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 06/28/2001 | WO2001045689A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2001 | WO2001045686A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045684A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045679A2 Use of chemotherapeutic agents for topical treatment |
| 06/28/2001 | WO2001045637A2 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides |
| 06/28/2001 | WO2001045552A1 Ingestible device for the release of substances at district locations in alimentary canal |
| 06/28/2001 | WO2001045509A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | WO2001005974A9 The il-1l1 gene and polypeptide products |
| 06/28/2001 | WO2000078322A3 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 06/28/2001 | WO2000077010A3 Substituted heterocycle fused gamma-carbolines |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000066731A3 Recombinant laminin 5 |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000066104A3 Ace-2 inhibiting compounds and methods of use thereof |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000042987A8 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections |
| 06/28/2001 | WO2000040569A8 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 06/28/2001 | WO1999000112A8 Sucralfate-containing composition and process for the preparation thereof |
| 06/28/2001 | US20010005726 Includes an organic solvent, a surfactant, and an oil; high in vivo bioavailability |
| 06/28/2001 | US20010005719 Compositions and methods for treatment of mitochondrial diseases |
| 06/28/2001 | DE19962936A1 New beta-aminoacid amide derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological disorders e.g. asthma, diabetes or rheumatoid arthritis |